Evotec SE (EVO) Gross Margin (2020 - 2025)
Evotec SE's (EVO) quarterly Gross Margin came in at 30.99% in Q4 2025, up 1015.0% year-on-year from 2.78% in Q4 2024, and up 100.08% quarter-over-quarter from 37830.94% in Q3 2025.
Evotec SE (EVO) Gross Margin (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Gross Margin across 6 years of filings, most recently posting 30.99% for Q4 2025.
- Gross Margin for Q4 2025 came in at 30.99%, up 1015.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 7811.12% (down 783135.0% YoY), and the FY2025 annual result was 14.49%, up 7.0% from the prior year.
- Gross Margin came in at 30.99% for Q4 2025 at Evotec SE, up from 37830.94% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 30.99% in Q4 2025 to a low of 37830.94% in Q3 2025.
- The 5-year median for Gross Margin is 19.61% (2022), against an average of 2502.37%.
- Peak annual rise in Gross Margin reached 1015 bps in 2025, while the deepest fall reached 3784083 bps in 2025.
- Evotec SE's Gross Margin stood at 23.08% in 2021, then dropped by 22 bps to 17.94% in 2022, then jumped by 32 bps to 23.68% in 2023, then retreated by 12 bps to 20.84% in 2024, then jumped by 49 bps to 30.99% in 2025.
- The last three Gross Margin figures came in at 30.99% (Q4 2025), 37830.94% (Q3 2025), and 20.84% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -293.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.20% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 65.25% |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.99% |
| Sep 30, 2025 | -37,830.94% |
| Dec 31, 2024 | 20.84% |
| Sep 30, 2024 | 9.89% |
| Dec 31, 2023 | 23.68% |
| Sep 30, 2023 | 19.27% |
| Jun 30, 2023 | 27.20% |
| Dec 31, 2022 | 17.94% |
| Sep 30, 2022 | 16.34% |
| Jun 30, 2022 | 17.94% |
| Mar 31, 2022 | 19.61% |
| Dec 31, 2021 | 23.08% |
| Sep 30, 2021 | 27.04% |
| Jun 30, 2021 | 18.54% |
| Mar 31, 2021 | 23.05% |
| Dec 31, 2020 | 17,804.90% |